Antares Vision (AV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Nov, 2025Executive summary
9M 2025 consolidated revenues reached €134M, up 5% year-over-year, with all business units growing except 'Other'.
Orders increased by 9% year-over-year, mainly driven by multi-year SCT contracts (+65% Y/Y).
The restructuring project is showing positive results despite a complex external scenario and geopolitical tensions.
Leadership changes include the appointment of Fabio Forestelli as CEO and the co-optation of Stefano De Rosa as executive director.
Financial highlights
9M 2025 revenues reached €133.7m–€134M, up 5% year-over-year; 3Q 2025 revenues were €43.3m, up 7% year-over-year.
Net Financial Position at €85M (€82.8M excl. FX) at 9M 2025, slightly improved from €83.7M in 2024.
Recurring revenues (Services + SCT) grew 7% in 9M 2025, accounting for 45% of total revenues.
Adjusted EBITDA margin for FY 2025 is expected at the lower end of the 16-18% guidance.
NFP/EBITDA ratio forecasted at 2.2x-2.5x for FY 2025.
Outlook and guidance
FY 2025 revenue growth now expected to be flat or slightly positive due to a slowdown in orders, especially in LS&C.
Adjusted EBITDA margin anticipated at the lower end of the 16-18% guidance range, supported by cost control and efficiency initiatives.
NFP/EBITDA ratio expected around 2.2x-2.5x, including FX effects.
The company remains committed to long-term objectives, innovation, and sustainable management.
Latest events from Antares Vision
- FY 2025 revenues fell 2% to €204M, with SCT and recurring revenue growth offsetting Life Science weakness.AV
Q4 202513 Feb 2026 - Orders up 14%, revenues rose 3.3%, EBITDA doubled, and net loss narrowed in 1H 2025.AV
Q2 202512 Sep 2025 - Margins and cash flow improved as orders rose and full-year guidance was confirmed.AV
Q3 202413 Jun 2025 - Adjusted EBITDA rebounded to €3.4M as recurring business and margins improved.AV
Q2 202413 Jun 2025 - 2024-2026 plan aims for strong revenue and EBITDA growth, driven by innovation and efficiency.AV
Strategy Update13 Jun 2025 - Q1 2025 orders up 25% year-over-year, with recurring revenues at 49% of total.AV
Q1 20256 Jun 2025 - Profitability and cash flow surged, with recurring revenues and leverage improving.AV
H2 20246 Jun 2025 - Strong 4Q drives revenue, margin, and order growth, setting up a positive 2025 outlook.AV
Q4 20246 Jun 2025